Cargando…
Biological and clinical characterization of paclitaxel poliglumex (PPX, CT-2103), a macromolecular polymer–drug conjugate
Paclitaxel is a widely used chemotherapeutic agent; however, its therapeutic index is limited by low tumor exposure and high systemic exposure. Paclitaxel poliglumex (PPX) is macromolecular drug conjugate that links paclitaxel with a biodegradable polymer, poly-L-glutamic acid. PPX enhances tumor ex...
Autores principales: | Chipman, Stewart D, Oldham, Fred B, Pezzoni, Gabriella, Singer, Jack W |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2676644/ https://www.ncbi.nlm.nih.gov/pubmed/17722272 |
Ejemplares similares
-
Procoagulant inhibitory properties of paclitaxel poliglumex
por: Nemunaitis, John, et al.
Publicado: (2010) -
Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer
por: Paz-Ares, L, et al.
Publicado: (2008) -
The exopolyphosphatase TbrPPX1 of Trypanosoma brucei
por: Luginbuehl, Edith, et al.
Publicado: (2011) -
Fermi-Dirac correlations in $Zo \to ppX$
por: Kucharczyk, M, et al.
Publicado: (2004) -
ppx: Programmatic access to proteomics data repositories
por: Fondrie, William E, et al.
Publicado: (2021)